---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-000210"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:52:51.932569+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Profound Medical TULSA-PRO installed base reaches 78 systems, exceeding 2025 target of 75

## Summary
- TULSA-PRO installed base stood at 78 systems as of Dec. 31, 2025, above the goal of 75.
- Qualified sales pipeline grew to 97 new systems in Verify, Negotiate, or Contracting stages.
- CEO expects higher patient treatment rates and recurring revenue as installed base expands.
- Q4 and full-year 2025 financial results to be released near end of February 2026.

## SEC filing metadata
- accession: 0001171843-26-000210
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184326000210/0001171843-26-000210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184326000210/f8k_011226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-000210
- JSON: https://secwatch.observer/filing/0001171843-26-000210.json
- Plain text: https://secwatch.observer/filing/0001171843-26-000210.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.